TuHURA Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
TuHURA Biosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Jun 2020Jun 2019Jun 2018
Revenue & Gross Profit
Revenue0.000.000.000.000.000.000.00
Cost of Revenue0.120.000.000.000.000.000.00
Gross Profit-0.120.000.000.000.000.000.00
Operating Expenses
Research & Development13.349.407.934.883.633.667.13
Selling, General & Administrative4.204.142.012.384.514.744.04
Operating Expenses17.5313.559.727.11-9.208.4011.17
Operating Income-17.65-13.55-9.72-7.11-7.02-8.40-11.17
Other Income/Expense
Interest Income0.360.090.060.000.000.060.03
Interest Expense4.14-0.020.000.630.000.000.00
Other Income/Expense-4.030.040.290.730.290.290.00
Income
Income Before Tax-21.68-29.32-9.37-7.02-7.02-8.05-11.14
Income Tax Expense0.000.010.200.000.000.000.00
Net Income-21.68-29.32-9.37-7.02-9.13-8.05-11.14
Net Income - Continuous Operations-21.68-29.32-9.37-7.020.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-17.43-13.37-8.99-6.01-8.13-8.38-11.15
EBIT-17.65-13.55-9.37-6.39-8.14-8.40-11.17
Depreciation & Amortization0.120.180.370.380.000.000.00
Earnings Per Share
Basic EPS-1.00-2.00-1.00-1.0030.00-3.00-5.00
Diluted EPS-1.00-2.00-1.00-1.0030.00-3.00-5.00
Basic Shares Outstanding18.6611.8912.1812.180.302.572.09
Diluted Shares Outstanding18.6611.8912.1812.180.302.572.09